Company logo

ONCT - Oncternal Therapeutics, Inc.

NASDAQ -> Healthcare -> Biotechnology
San Diego, United States
Type: Equity

ONCT price evolution
ONCT
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $6.7 $14.93 $15.83 $11.24
Short term investments $27.56 $25.38 $29.67 $43.07
Net receivables
Inventory
Total current assets $36.06 $42.49 $50.08 $57.92
Long term investments
Property, plant & equipment $0.26 $0.29 $0.37 $0.05
Goodwill & intangible assets
Total noncurrent assets $0.67 $0.7 $0.7 $0.36
Total investments $27.56 $25.38 $29.67 $43.07
Total assets $36.73 $43.2 $50.77 $58.28
Current liabilities
Accounts payable $1.15 $2.13 $2.22 $1.96
Deferred revenue
Short long term debt $0.17 $0.15 $0.14 $0.05
Total current liabilities $5.2 $5.15 $4.83 $5.49
Long term debt $0.14 $0.19 $0.22
Total noncurrent liabilities $1.48 $1.05 $0.76 $0.31
Total debt $0.32 $0.34 $0.37 $0.05
Total liabilities $6.68 $6.2 $5.59 $5.79
Shareholders' equity
Retained earnings -$197.78 -$188.62 -$178.75 -$169.79
Other shareholder equity $0 -$0.01 $0.01
Total shareholder equity $30.05 $37 $45.18 $52.49
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $6.7 $37.14 $90.77 $116.74
Short term investments $27.56 $26.58
Net receivables $0.63 $0.18
Inventory
Total current assets $36.06 $67.29 $92.85 $118
Long term investments
Property, plant & equipment $0.26 $0.09 $0.07 $0.04
Goodwill & intangible assets
Total noncurrent assets $0.67 $1.36 $0.73 $0.81
Total investments $27.56 $26.58
Total assets $36.73 $68.65 $93.58 $118.81
Current liabilities
Accounts payable $1.15 $2.92 $1.96 $1.14
Deferred revenue $1.63
Short long term debt $0.17 $0.09 $0.07 $0.04
Total current liabilities $5.2 $7.68 $5.46 $5.86
Long term debt $0.14
Total noncurrent liabilities $1.48
Total debt $0.32 $0.09 $0.07 $0.04
Total liabilities $6.68 $7.68 $5.46 $5.86
Shareholders' equity
Retained earnings -$197.78 -$158.3 -$114.13 -$82.8
Other shareholder equity $0 $0.01
Total shareholder equity $30.05 $60.97 $88.12 $112.95
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $0.3 $0.18 $0.11 $0.2
Cost of revenue
Gross Profit $0.3 $0.18 $0.11 $0.2
Operating activities
Research & development $6.67 $7.47 $6.58 $9.03
Selling, general & administrative $3.26 $3.09 $3.07 $3.31
Total operating expenses $9.93 $10.57 $9.65 $12.35
Operating income -$9.64 -$10.39 -$9.54 -$12.14
Income from continuing operations
EBIT -$9.16 -$9.86 -$8.97 -$11.49
Income tax expense
Interest expense
Net income
Net income -$9.16 -$9.86 -$8.97 -$11.49
Income (for common shares) -$9.16 -$9.86 -$8.97 -$11.49
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $0.79 $1.49 $4.32 $3.38
Cost of revenue
Gross Profit $0.79 $1.49 $4.32 $3.38
Operating activities
Research & development $29.75 $32.98 $24.09 $12.54
Selling, general & administrative $12.75 $13.46 $11.6 $8.37
Total operating expenses $42.5 $46.44 $35.68 $20.92
Operating income -$41.71 -$44.95 -$31.37 -$17.54
Income from continuing operations
EBIT -$39.48 -$44.17 -$31.33 -$17.23
Income tax expense
Interest expense
Net income
Net income -$39.48 -$44.17 -$31.33 -$17.23
Income (for common shares) -$39.48 -$44.17 -$31.33 -$17.23
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$9.16 -$9.86 -$8.97 -$11.49
Operating activities
Depreciation $0.03 $0.07 $0.04 $0.04
Business acquisitions & disposals
Stock-based compensation $2.22 $1.72 $1.68 $1.89
Total cash flows from operations -$6.42 -$5.51 -$9.26 -$10.97
Investing activities
Capital expenditures
Investments -$1.81 $4.66 $13.85 -$16.05
Total cash flows from investing -$1.81 $4.66 $13.85 -$16.05
Financing activities
Dividends paid
Sale and purchase of stock -$0 -$0.05 -$0 $1.12
Net borrowings
Total cash flows from financing -$0 -$0.05 -$0 $1.12
Effect of exchange rate
Change in cash and equivalents -$8.23 -$0.91 $4.59 -$25.9
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$39.48 -$44.17 -$31.33 -$17.23
Operating activities
Depreciation $0.17 $0.18 $0.17 $0.15
Business acquisitions & disposals
Stock-based compensation $7.5 $7.43 $5.88 $1.56
Total cash flows from operations -$32.16 -$36.7 -$26.59 -$17.5
Investing activities
Capital expenditures
Investments $0.65 -$26.5
Total cash flows from investing $0.65 -$26.5
Financing activities
Dividends paid
Sale and purchase of stock $1.07 $9.58 $0.62 $113.88
Net borrowings $0.3
Total cash flows from financing $1.07 $9.58 $0.62 $114.18
Effect of exchange rate
Change in cash and equivalents -$30.45 -$53.62 -$25.97 $96.69
Fundamentals
Market cap $24.17M
Enterprise value $17.79M
Shares outstanding 2.95M
Revenue $785.00K
EBITDA -$39.30M
EBIT -$39.48M
Net Income -$39.48M
Revenue Q/Q 73.68%
Revenue Y/Y -47.32%
P/E ratio -0.61
EV/Sales 22.67
EV/EBITDA -0.45
EV/EBIT -0.45
P/S ratio 30.79
P/B ratio 0.80
Book/Share 10.19
Cash/Share 2.27
EPS -$13.39
ROA -83.56%
ROE -95.87%
Debt/Equity 0.22
Net debt/EBITDA 0.00
Current ratio 6.94
Quick ratio 6.94